Related Experiment Video
Updated: Aug 11, 2026

Multi-Gene Single Nucleotide Polymorphism Detection in Gastric Cancer Based on Ion Semiconductor Sequencing Platform
Published on: May 10, 2024
Chemotherapy for gastric cancer
Javier Sastre1, Jose Angel Garcia-Saenz, Eduardo Diaz-Rubio
1Servicio de Oncologia Medica, HCU San Carlos, c/Martin Lagos s/n 28040 Madrid, Spain. jsastre.hcsc@salud.madrid.org
Palliative chemotherapy offers survival benefits for metastatic gastric cancer. Adjuvant immunochemotherapy and postoperative chemoradiation show promise for resected cases, though neoadjuvant therapies require further investigation.
Area of Science:
- Oncology
- Gastrointestinal Oncology
Background:
- Metastatic gastric cancer is largely incurable, necessitating palliative treatments.
- Chemotherapy, both single-agent and combination, demonstrates activity in metastatic disease.
Purpose of the Study:
- To review current treatment strategies for metastatic and localized gastric cancer.
- To evaluate the efficacy of adjuvant, neoadjuvant, and palliative therapies.
Main Methods:
- Review of phase II and III studies on chemotherapy and chemoradiation for gastric cancer.
- Analysis of adjuvant immunochemotherapy and neoadjuvant treatment data.
Main Results:
- Palliative chemotherapy improves survival in metastatic gastric cancer with objective response rates of 10-60%.
- Adjuvant chemotherapy lacks survival advantage, but immunochemotherapy may benefit resected patients.
- Postoperative chemoradiation is standard in North America for resected gastric cancer.
- Neoadjuvant therapies show promising results in phase II studies.
Conclusions:
- Palliative chemotherapy is a cornerstone for metastatic gastric cancer.
- Adjuvant immunochemotherapy and postoperative chemoradiation offer survival benefits in specific patient groups.
- Neoadjuvant chemotherapy and chemoradiation are experimental but promising, requiring further phase III trials.
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
